$23.75 +0.05 (0.21%) Ariad Pharmaceuticals Inc - NASDAQ

Jan. 20, 2017 | 04:00 PM

Quotes

  1. Quotes

  2. Charts

  3. Analysis

  4. Options

  5. Historical



Last Trade: 23.75
Trade Time: Jan 20 04:00 PM Eastern Daylight Time
Change: +0.05 (0.21%)
Prev Close: 23.70
Open: 23.73
Bid: 23.75
Ask: 23.76
  1. Ariad Put Off Potential Suitor Amid 'Aggressive' Takeda Bid: RBC

    Investors Business Daily | Jan. 20, 2017 | 17:25PM EST
  2. Biotech Stocks Might Catalyze, Or Plunge, On 4 Key Sectors In 2017

    Investors Business Daily | Jan. 20, 2017 | 07:00AM EST
  3. Biotech Blahs: Out Of Favor But Great For Stock Pickers

    TalkMarkets | Jan. 3, 2017 | 02:49AM EST
  4. Ariad Pharma Could Draw M&A Fire Ahead Of Second Cancer Drug Win

    Investors Business Daily | Dec. 7, 2016 | 15:20PM EST
  5. Pharmaceutical Stocks Surge After Republican Victory

    TalkMarkets | Nov. 9, 2016 | 12:48PM EST
  6. Fundamentals Remain Strong In The Pharma Sector

    TalkMarkets | Nov. 5, 2016 | 18:49PM EST
  7. 5 Stocks To Watch Before The Market Opens On Monday- November 7

    TalkMarkets | Nov. 4, 2016 | 16:30PM EST
  8. Biotech Stock Roundup: Ariad Down On Drug Pricing Tweet, Regeneron Study On Clinical Hold

    TalkMarkets | Oct. 19, 2016 | 14:27PM EST
  9. A Fresh Breakdown For iShares Nasdaq Biotechnology

    TalkMarkets | Oct. 15, 2016 | 11:45AM EST
  10. Will These 5 Drug Stocks Be Big Winners This Earnings Season?

    TalkMarkets | Oct. 13, 2016 | 10:54AM EST
  11. Biotech Stocks Pause At Resistance: IBB

    TalkMarkets | Sep. 26, 2016 | 23:20PM EST
  12. Ariad Announces FDA Has Given Clearance To Begin Clinical Development Trial

    Benzinga | Feb. 1, 2016 | 14:49PM EST
  13. Benzinga's Top Initiations

    Benzinga | Jan. 19, 2016 | 09:55AM EST
  14. ARIAD Elects of Alex Denner as Chairman of the Board of Directors

    Benzinga | Jan. 10, 2016 | 18:30PM EST
  15. Mid-Morning Market Update: Markets Open Lower; Dow Chemical And DuPont Announce Merger

    Benzinga | Dec. 11, 2015 | 10:12AM EST
Trading Center